Search Results - "mRNA vaccine"

Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study by Wataru Mimura, Chieko Ishiguro, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda

Connect to this object online.

Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore by Celine Y. Tan, Calvin J. Chiew, Vernon J. Lee, Benjamin Ong, David Chien Lye, Kelvin Bryan Tan

Connect to this object online.

Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE-An Observational Study by Subhashini Ganesan, Subhashini Ganesan, Latifa Mohammad Baynouna Al Ketbi, Nawal Al Kaabi, Nawal Al Kaabi, Mohammed Al Mansoori, Noura Nasser Al Maskari, Mariam Saif Al Shamsi, Aysha Saeed Alderei, Hamada Nasser El Eissaee, Rudina Mubarak Al Ketbi, Noura Saeed Al Shamsi, Khuloud Mohammed Saleh, Aysha Fahad Al Blooshi, Flavia Martinez Cantarutti, Katherine Warren, Faheem Ahamed, Walid Zaher, Walid Zaher, Walid Zaher, Walid Zaher

Connect to this object online.

Autoimmune Hemolytic Anemia After mRNA COVID Vaccine by Zainab Fatima MD, Blair R. A. Reece MD, MHS, J. Suzanne Moore MD, Robert T. Means MD

Connect to this object online.

New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 cases by Haiwen Gui, BS, Peter A. Young, MPAS, Jodi Y. So, BA, Marlyanne Pol-Rodriguez, MD, Kerri E. Rieger, MD, PhD, Matthew A. Lewis, MD, MPH, Marten C.G. Winge, MD, PhD, Gordon H. Bae, MD

Connect to this object online.

A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome by Yoshihiro Matsuda, Yoshio Kawakami, Masaya Kawamoto, Yoji Hirai, Shin Morizane

Connect to this object online.

Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France by Rebecca Grant, Tiffany Charmet, Laura Schaeffer, Simon Galmiche, Yoann Madec, Cassandre Von Platen, Olivia Chény, Faïza Omar, Christophe David, Alexandra Rogoff, Juliette Paireau, Simon Cauchemez, Fabrice Carrat, Alexandra Septfons, Daniel Levy-Bruhl, Alexandra Mailles, Arnaud Fontanet

Connect to this object online.

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K Ariën, Maria E Goossens

Connect to this object online.

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens

Connect to this object online.

Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers by Salvatore Zaffina, Claudia Alteri, Alessandra Ruggiero, Nicola Cotugno, Maria Rosaria Vinci, Vincenzo Camisa, Anna Paola Santoro, Rita Brugaletta, Gloria Deriu, Eva Piano Mortari, Ane Fernandez Salinas, Cristina Russo, Stefania Ranno, Luana Coltella, Luna Colagrossi, Ottavia Porzio, Andrea Onetti Muda, Massimiliano Raponi, Marta Ciofi degli Atti, Caterina Rizzo, Alberto Villani, Paolo Rossi, Paolo Palma, Rita Carsetti, Carlo Federico Perno

Connect to this object online.

Applications and challenges of biomaterial mediated mRNA delivery by Huapan Fang, Qian Chen

Connect to this object online.

COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events by William E. Fitzsimmons

Connect to this object online.

Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literatureCapsule Summary by Jordan E. Buckley, MD, Laura N. Landis, BA, Ronald P. Rapini, MD

Connect to this object online.

Dendrimer-based nanocomposites for the production of RNA delivery systems by Chiou Chyi Lim, Le Yi Chia, Palanirajan Vijayaraj Kumar

Connect to this object online.

mRNA cancer vaccines: Advances, trends and challenges by Qing He, Hua Gao, Dejiang Tan, Heng Zhang, Jun-zhi Wang

Connect to this object online.

An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics by Rahul G. Ingle, Wei-Jie Fang

Connect to this object online.

Application of microfluidic technologies on COVID-19 diagnosis and drug discovery by Zhun Lin, Zhengyu Zou, Zhe Pu, Minhao Wu, Yuanqing Zhang

Connect to this object online.

Recent progress in mRNA cancer vaccines by Ruhui Yao, Chunyuan Xie, Xiaojun Xia

Connect to this object online.

Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Associat... by Chang-Yu Hsieh, Shan-Chi Yu, Jia-Arng Lee, Tsen-Fang Tsai

Connect to this object online.

mRNA-Based Therapeutics in Cancer Treatment by Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu

Connect to this object online.